Transcenta Holding Limited (HKG:6628)
1.110
+0.040 (3.74%)
Jul 10, 2026, 1:43 PM HKT
Transcenta Holding Market Cap
Transcenta Holding has a market cap or net worth of 456.51 million as of July 9, 2026. Its market cap has decreased by -30.56% in one year.
Market Cap
456.51M
Enterprise Value
581.28M
Revenue
8.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.11
Market Cap Chart
Since April 27, 2022, Transcenta Holding's market cap has decreased from 2.75B to 456.51M, a decrease of -83.42%. That is a compound annual growth rate of -34.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 456.51M | -52.14% |
| Dec 31, 2025 | 953.77M | 274.36% |
| Dec 31, 2024 | 254.77M | -82.96% |
| Dec 29, 2023 | 1.50B | 14.88% |
| Dec 30, 2022 | 1.30B | -52.74% |
| Apr 27, 2022 | 2.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cutia Therapeutics | 962.93M |
| Kintor Pharmaceutical | 943.18M |
| Shanghai Bio-heart Biological Technology | 788.67M |
| Brii Biosciences | 750.68M |
| Wuhan YZY Biopharma | 736.63M |
| JW (Cayman) Therapeutics Co. | 722.49M |
| 3D Medicines | 553.32M |
| Uni-Bio Science Group | 513.53M |